XML 73 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Interests in subsidiaries (Tables)
 12 Months Ended
Jun. 30, 2020
Investments accounted for using equity method [abstract]  
Summary of interest in subsidiaries
The consolidated financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policy described in note 2:
 
 
  
 
  
Ownership interest
 
Name
  
Principal place of business /
Country of incorporation
  
2020
%
 
 
2019
%
 
Kazia Laboratories Pty Ltd
  
Australia
  
 
100.00
% 
 
 
100.00
% 
Kazia Research Pty Ltd
  
Australia
  
 
100.00
% 
 
 
100.00
% 
Kazia Therapeutics Inc.
  
United States of America
  
 
100.00
% 
 
 
100.00
% 
Glioblast Pty Ltd
  
Australia
  
 
100.00
% 
 
 
100.00
%